By Professor Kate Hilda Moore

Journal articles

Chiarelli PE; Moore KH, 2008, 'Exercise, feedback, and biofeedback', , pp. 184 - 189, http://dx.doi.org/10.1007/978-1-84628-505-9_19

Morris AR; Moore KH, 2008, 'Extracorporeal magnetic stimulation', , pp. 196 - 200, http://dx.doi.org/10.1007/978-1-84628-505-9_21

Moore KH; Karantanis E, 2008, 'Outcome measures in pelvic floor rehabilitation', , pp. 162 - 174, http://dx.doi.org/10.1007/978-1-84628-505-9_17

Baessler K; Schüssler B; Burgio KL; Moore KH; Norton PA; Stanton SL, 2008, 'Pelvic floor re-education: Principles and Practice', Pelvic Floor Re Education Principles and Practice, pp. 1 - 302, http://dx.doi.org/10.1007/978-1-84628-505-9

Baessler K; Schüssler B; Burgio KL; Moore KH; Norton PA; Stanton SL, 2008, 'Preface', Pelvic Floor Re Education Principles and Practice, http://dx.doi.org/10.1007/978-1-84628-505-9

Morris AR; Westbrook JI; Moore KH, 2008, 'A longitudinal study over 5 to 10 years of clinical outcomes in women with idiopathic detrusor overactivity', BJOG: An International Journal of Obstetrics & Gynaecology, 115, pp. 239 - 246, http://dx.doi.org/10.1111/j.1471-0528.2007.01527.x

Allen WA; Leek H; Izurieta A; Moore KH, 2008, 'Update: the “Contiform” intravaginal device in four sizes for the treatment of stress incontinence', International Urogynecology Journal, 19, pp. 757 - 761, http://dx.doi.org/10.1007/s00192-007-0519-1

Mansfield KJ; Liu L; Moore KH; Vaux KJ; Millard RJ; Burcher E, 2007, 'Molecular characterization of M-2 and M-3 muscarinic receptor expression in bladder from women with refractory idiopathic detrusor overactivity', BJU INTERNATIONAL, 99, pp. 1433 - 1438, http://dx.doi.org/10.1111/j.1464-410X.2007.06866.x

Millard R; Mansfield K; Vaux V; Moore K; Burcher E, 2007, 'Molecular characterisation of M-2 and M-3 muscarinic receptor expression in bladder from female patients with refractory idiopathic detrusor overactivity', BJU INTERNATIONAL, 99, pp. 15 - 15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000243303700050&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sansoni J; Marosszeky N; Hawthorne G; Sansoni E; Moore K, 2007, 'Revised, short, faecal incontinence assessment instruments for clinical practice, epidemiological and outcomes research', NEUROUROLOGY AND URODYNAMICS, 26, pp. 638 - 639, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248534000030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chua WC-N; Liu L; Mansfield KJ; Vaux KJ; Moore KH; Millard RJ; Burcher E, 2007, 'Age-related changes of P2X1 receptor mRNA in the bladder detrusor from men with and without bladder outlet obstruction', Experimental Gerontology, 42, pp. 686 - 692, http://dx.doi.org/10.1016/j.exger.2007.02.003

Woodman J; Thornton MJ; Burns H; King DW; Moore CH, 2007, 'Anal incontinence after transanal versus transvaginal repair of rectocele: matched pair cohort analysis', Australian & New Zealand Continence Journal, 13, pp. 40 - 45

Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC, 2007, 'Duloxetine compared with placebo for treating women with symptoms of overactive bladder', BJU International, 100, pp. 337 - 345, http://dx.doi.org/10.1111/j.1464-410x.2007.06980.x

Morris AR; O'Sullivan R; Dunkley P; Moore KH, 2007, 'Extracorporeal Magnetic Stimulation is of Limited Clinical Benefit to Women with Idiopathic Detrusor Overactivity: A Randomized Sham Controlled Trial', European Urology, 52, pp. 876 - 883, http://dx.doi.org/10.1016/j.eururo.2007.02.026

Moore CH; Sarma S, 2007, 'The changing face of a detrusor overactivity therapy in Australia', Australian & New Zealand Continence Journal, 13, pp. 90 - 94

FOOTE AJ; MOORE KH, 2007, 'The cost of urogynaecological treatments: Which are more cost‐effective?', Australian and New Zealand Journal of Obstetrics and Gynaecology, 47, pp. 240 - 246, http://dx.doi.org/10.1111/j.1479-828x.2007.00726.x

Karantanis E; Wang K; Fynes M; Moore K, 2006, '24-hour pad test: A comparison of normal ranges between two countries and according to the type of pad used.', NEUROUROLOGY AND URODYNAMICS, 25, pp. 608 - 609, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241044500083&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kuteesa W; Moore KH, 2006, 'Anticholinergic drugs for overactive bladder', Australian Prescriber, 29, pp. 22 - 24, http://dx.doi.org/10.18773/austprescr.2006.012

Kuteesa WMA; Moore KH, 2006, 'Overative bladder in women: Advances in management', Medicine Today, 7, pp. 44

Morris AR; Ho MT; Lapsley H; Walsh J; Gonski P; Moore KH, 2005, 'Costs of managing urinary and faecal incontinence in a sub‐acute care facility: A “bottom‐up” approach', Neurourology and Urodynamics, 24, pp. 56 - 62, http://dx.doi.org/10.1002/nau.20079

Schofield EC; Clausen JA; Burcher E; Moore KH, 2005, 'GAP‐43 immunoreactivity of subepithelial and detrusor muscle nerve fibres in patients with refractory idiopathic detrusor overactivity', Neurourology and Urodynamics, 24, pp. 325 - 333, http://dx.doi.org/10.1002/nau.20140

Mansfield KJ; Liu L; Mitchelson FJ; Moore KH; Millard RJ; Burcher E, 2005, 'Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT–PCR: changes in ageing', British Journal of Pharmacology, 144, pp. 1089 - 1099, http://dx.doi.org/10.1038/sj.bjp.0706147

Karantanis E; Allen W; Stevermuer TL; Simons AM; O’Sullivan R; Moore KH, 2005, 'The repeatability of the 24-hour pad test', International Urogynecology Journal, 16, pp. 63 - 68, http://dx.doi.org/10.1007/s00192-004-1199-8

Karantanis E; Fynes M; Moore KH; Stanton SL, 2004, 'Comparison of the ICIQ-SF and 24-hour pad test with other measures for evaluating the severity of urodynamic stress incontinence', International Urogynecology Journal and Pelvic Floor Dysfunction, 15, pp. 111 - 116, http://dx.doi.org/10.1007/s00192-004-1123-2

Morris AR; Mullan G; Roscioli T; Buckley MF; Moore KH, 2004, 'A genetic linkage study of detrusor overactivity', NEUROUROLOGY AND URODYNAMICS, 23, pp. 404 - 406, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223051900007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Burcher E; Mansfield KJ; Liu L; Vaux KJ; Moore KH, 2004, 'Age-related decrease in muscarinic M3 but not M2 receptor mRNA in the male detrusor muscle.', NEUROUROLOGY AND URODYNAMICS, 23, pp. 453 - 455, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000223051900041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC; Chancellor MB, 2004, 'Duloxetine reduced the frequency of stress urinary incontinence episodes and improved quality of life in European women', Evidence Based Obstetrics and Gynecology, 6, pp. 196 - 199, http://dx.doi.org/10.1016/j.ebobgyn.2004.08.006

Blackwell AL; Yoong W; Moore KH, 2004, 'Criterion validity, test‐retest reliability and sensitivity to change of the St George urinary incontinence score', BJU International, 93, pp. 331 - 335, http://dx.doi.org/10.1111/j.1464-410x.2003.04610.x

Millard R; Moore CH; Rencken R; Yalcin I; Bump RC, 2004, 'Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.', British Journal of Urology, 93, pp. 311 - 318

Moore CH, 2004, 'Duloxetine: a new approach for treating stress urinary incontinence.', International Journal of Gynecology and Obstetrics, 86, pp. 53 - 62

Deans CL; Morris AR; Moore CH; O Sullivan R, 2004, 'Voiding difficulty and other adverse events after tension free vaginal tape.', Australian & New Zealand Continence Journal, 10, pp. 34 - 41

Ray FR; Moore KH; Hansen MA; Barden JA, 2003, 'Loss of purinergic P2X receptor innervation in human detrusor and subepithelium from adults with sensory urgency', Cell and Tissue Research, 314, pp. 351 - 359, http://dx.doi.org/10.1007/s00441-003-0788-z

Morris AR; Moore KH, 2003, 'The Contiform incontinence device ? efficacy and patient acceptability', International Urogynecology Journal and Pelvic Floor Dysfunction, 14, pp. 412 - 417, http://dx.doi.org/10.1007/s00192-003-1094-8

Herbison P; Hay-Smith J; Ellis G; Moore K, 2003, 'Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review', BMJ, 326, pp. 841.1 - 841.1, http://dx.doi.org/10.1136/bmj.326.7394.841

O'Sullivan R; Simons A; Prashar S; Anderson P; Louey M; Moore KH, 2003, 'Is objective cure of mild undifferentiated incontinence more readily achieved than that of moderate incontinence? Costs and 2-year outcome', International Urogynecology Journal, 14, pp. 193 - 198, http://dx.doi.org/10.1007/s00192-003-1062-3

Qi JC; Li L; Li Y; Moore K; Madigan MC; Katsoulotos G; Krilis SA, 2003, 'An antibody raised against in vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc epsilon RI(+), tryptase(-), and chymase(-) in a variety of human tissues.', J Histochem Cytochem, 51, pp. 643 - 653, http://dx.doi.org/10.1177/002215540305100510

Dietz HP; Moore KH; Steensma AB, 2003, 'Antenatal pelvic organ mobility is associated with delivery mode', Australian and New Zealand Journal of Obstetrics and Gynaecology, 43, pp. 70 - 74, http://dx.doi.org/10.1046/j.0004-8666.2003.00017.x

Blackwell A; Moore CH, 2003, 'Dose detrusor overactivity ever cease? Repeat urodynamic testing at 1 to 9 years', Neurology and Urodynamics, 22, pp. 462 - 463

Westbrook JI; Moore CH, 2003, 'Idiopathic detrusor overactivity in women- A 5-10 year longitudinal study of outcomes', Neurourology and Urodynamics, 22, pp. 460 - 462

O Sullivan R; Simons A; Prashar S; Anderson P; louey A; Moore CH, 2003, 'Is objective cure of mild undifferentiated more readily achieved than that of moderate incontinence?', International Journal Urogynaecology, 14, pp. 193 - 198

Mansfield FJ; Mitchelson FJ; Moore CH; Burcher EF, 2003, 'Muscarinic receptor binding in human detrusor-age related changes', Neurourology and Urodynamics, 22, pp. 527 - 529

Mansfield KJ; Mitchelson FJ; Moore KH; Burcher E, 2003, 'Muscarinic receptor subtypes in the human colon: lack of evidence for atypical subtypes', European Journal of Pharmacology, 482, pp. 101 - 109, http://dx.doi.org/10.1016/j.ejphar.2003.10.008

Moore KH; O'Sullivan RJ; Simons A; Prashar S; Anderson P; Louey M, 2003, 'Randomised controlled trial of nurse continence advisor therapy compared with standard urogynaecology regimen for conservative incontinence treatment: efficacy, costs and two year follow up.', BJOG, 110, pp. 649 - 657, https://www.ncbi.nlm.nih.gov/pubmed/12842055

Karantanis E; O'Sullivan R; Moore KH, 2003, 'The 24-hour pad test in continent women and men: normal values and cyclical alterations', BJOG An International Journal of Obstetrics & Gynaecology, 110, pp. 567 - 571, http://dx.doi.org/10.1016/s1470-0328(03)02115-3

Karantanis E; O'Sullivan R; Moore KH, 2003, 'The 24‐hour pad test in continent women and men: normal values and cyclical alterations', BJOG: An International Journal of Obstetrics & Gynaecology, 110, pp. 567 - 571, http://dx.doi.org/10.1046/j.1471-0528.2003.02115.x

Green P; Smoker I; Moore CH, 2003, 'Urinary incontinence in sub-acute care- a retrospective data analysis', Neurourology and Urodynamics, 110, pp. 567 - 571

Hay-Smith J; Herbison P; Ellis G; Moore K, 2002, 'Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.', Cochrane database of systematic reviews (Online : Update Software)

Hay-Smith J; Herbison P; Ellis G; Moore K, 2002, 'Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.', Cochrane Database of Systematic Reviews Online, pp. CD003781

Moore CH; Ho MT; Lapsley HM; Smoker I; Morris A; O Sullivan RA; Louey M; Green J; Werda J; Walsh J; Dowell CJ; Gonski PN; Shiaxates C; Poulos CJ, 2002, 'Development of a framework for economic and cost evaluations for continence conditions', Australian Continence Journal, 8, pp. 59 - 62

Moore KH; Lam DSH; Lynch W; Burcher E, 2002, 'The tachykinin NK-2 receptor antagonist SR48968 does not block noncholinergic contractions in unstable human bladder', Peptides, 23, pp. 1155 - 1160, http://dx.doi.org/10.1016/s0196-9781(02)00049-9

Back to profile page